Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-azacytidine Added to Standard Chemotherapy in Elderly AML
NCT00915252Phase 2Completed
- Sponsor
- Universitätsklinikum Münster
- Start
- Jul 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azacitidine in acute myeloid leukemia (AML), sponsored by Universitätsklinikum Münster. Started Jul 2009; status: completed.
02
Drugs
azacitidine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT00915252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915252.